Hims & Hers will start selling a generic weight loss drug
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...
Becker's Hospital Review7h
Hims & Hers to sell generic weight loss drug in 2025
Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
kffhealthnews10h
Lawsuits Say GoodRx, PBMs Quash Reimbursements To Small Pharmacies
CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...
Morningstar1d
Hims & Hers Health Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Business Insider6d
Hims & Hers falls -14.6%
Hims & Hers (HIMS) is down -14.6%, or -$3.25 to $19.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks ...
Fatty Liver Disease: What Men Need to Know
Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.
Nasdaq4d
HIMS Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
Hims & Hers Health, Inc. HIMS is scheduled to report third-quarter 2024 results on Nov. 4, after the closing bell. In the last reported quarter, the company’s earnings per share (EPS) of 6 cents ...
California Healthline2mon
California Healthline Daily Edition
Whoever wins the presidency, the 2024 election has outsized implications for California. The elevation of Democratic Vice President Kamala Harris to the highest office in the land would make her the ...